ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q2 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $150,897,515 | +3.5% | 1,106,449 | +14.7% | 0.03% | +3.2% |
| Q1 2024 | $145,828,106 | +27.5% | 964,663 | +6.3% | 0.03% | +14.8% |
| Q4 2023 | $114,351,391 | +81.7% | 907,911 | +35.1% | 0.03% | +58.8% |
| Q3 2023 | $62,937,878 | +14.7% | 672,126 | +9.3% | 0.02% | +21.4% |
| Q2 2023 | $54,863,135 | -20.9% | 614,713 | -4.9% | 0.01% | -26.3% |
| Q1 2023 | $69,324,163 | -14.1% | 646,560 | -2.2% | 0.02% | -20.8% |
| Q4 2022 | $80,701,794 | +30.3% | 660,786 | +10.1% | 0.02% | +20.0% |
| Q3 2022 | $61,959,000 | +12.5% | 600,023 | +1.2% | 0.02% | +17.6% |
| Q2 2022 | $55,094,000 | -53.8% | 592,655 | -41.7% | 0.02% | -43.3% |
| Q1 2022 | $119,365,000 | -11.5% | 1,017,090 | +1.4% | 0.03% | -9.1% |
| Q4 2021 | $134,939,000 | -17.6% | 1,003,043 | -2.4% | 0.03% | -19.5% |
| Q3 2021 | $163,736,000 | +7.4% | 1,027,262 | -11.4% | 0.04% | +7.9% |
| Q2 2021 | $152,469,000 | +61.1% | 1,159,024 | +57.8% | 0.04% | +52.0% |
| Q1 2021 | $94,636,000 | -26.0% | 734,292 | -4.2% | 0.02% | -32.4% |
| Q4 2020 | $127,871,000 | +7.9% | 766,704 | -0.1% | 0.04% | -7.5% |
| Q3 2020 | $118,462,000 | +32.9% | 767,639 | +27.3% | 0.04% | +25.0% |
| Q2 2020 | $89,155,000 | +33.2% | 602,805 | +1.4% | 0.03% | +14.3% |
| Q1 2020 | $66,937,000 | -18.9% | 594,421 | +0.2% | 0.03% | +7.7% |
| Q4 2019 | $82,543,000 | -15.9% | 593,323 | -41.8% | 0.03% | 0.0% |
| Q3 2019 | $98,111,000 | -16.0% | 1,018,592 | +0.4% | 0.03% | -13.3% |
| Q2 2019 | $116,802,000 | +1000.5% | 1,014,346 | +1024.8% | 0.03% | +650.0% |
| Q1 2019 | $10,614,000 | +17.5% | 90,177 | -37.4% | 0.00% | +33.3% |
| Q4 2018 | $9,030,000 | -12.1% | 144,139 | -0.6% | 0.00% | 0.0% |
| Q3 2018 | $10,271,000 | +1.4% | 144,956 | -4.8% | 0.00% | 0.0% |
| Q2 2018 | $10,132,000 | – | 152,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
| Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
| Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
| VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
| EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
| Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
| Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
| Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
| Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
| Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |